Pharmaceutical Formulation Containing Gelling Agent
US-2015374631-A1 · Dec 31, 2015 · US
US12539277B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12539277-B2 |
| Application number | US-202117497289-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 8, 2021 |
| Priority date | Apr 9, 2019 |
| Publication date | Feb 3, 2026 |
| Grant date | Feb 3, 2026 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
There is provided a production method for a microcapsule in which cells are encapsulated with alginic acid and a polycation, the method including dropwise adding a cell suspension containing cells and alginic acid into a calcium ion-containing solution to obtain a liquid droplet in which the cells are encapsulated in alginic acid, and immersing the liquid droplet in a coating liquid containing a polycation, to obtain the microcapsule, where the coating liquid contains a calcium ion or a barium ion at a concentration of 0.1 mM or more and 50.0 mM or less. According to the production method of the present invention, it is possible to produce a microcapsule having a uniform shape and particle size.
Opening claim text (preview).
What is claimed is: 1 . A production method for a microcapsule in which cells are encapsulated with alginic acid and a polycation, the method comprising: dropwise adding a cell suspension containing alginic acid and the cells into a calcium ion-containing solution to obtain a liquid droplet in which the cells are encapsulated with alginic acid; and immersing the liquid droplet in a coating liquid containing a polycation to obtain the microcapsule, wherein the coating liquid contains a calcium ion or a barium ion at a concentration of 0.1 mM or more and 50.0 mM or less. 2 . The production method according to claim 1 , wherein the cell suspension has a viscosity of 50 mPa's or more and 500 mPa's or less. 3 . The production method according to claim 1 , wherein a molecular weight of the polycation is 1 kDa or more and 200 kDa or less. 4 . The production method according to claim 1 , wherein a molecular weight of the polycation is 1 kDa or more and 50 kDa or less. 5 . The production method according to claim 1 , wherein the polycation is poly-L-lysine or poly-L-ornithine. 6 . The production method according to claim 1 , wherein the coating liquid in which the liquid droplet is immersed is subjected to shaking treatment. 7 . The production method according to claim 1 , further comprising immersing the microcapsule in a solution containing alginic acid. 8 . The production method according to claim 7 , wherein the microcapsules after being immersed in the solution containing alginic acid are dispersed in a solution containing a calcium ion or a barium ion at a concentration of 0.1 mM or more and 50.0 mM or less. 9 . The production method according to claim 1 , wherein the cell is a cell that releases a physiologically active substance. 10 . The production method according to claim 9 , wherein the physiologically active substance is insulin. 11 . The production method according to claim 9 , wherein the cell is a cell in pancreatic islet. 12 . The production method according to claim 9 , wherein in the microcapsule, a mesenchymal stem cell or a mesenchymal stem cell group is encapsulated with alginic acid and a polycation together with the cell. 13 . The production method according to claim 1 , wherein the coating liquid contains a calcium ion or a barium ion at a concentration of 0.1 mM or more and 20.0 mM or less. 14 . The production method according to claim 1 , wherein the coating liquid contains a calcium ion or a barium ion at a concentration of 0.2 mM or more and 10.0 mM or less. 15 . The production method according to claim 1 , wherein the coating liquid contains a calcium ion at a concentration of 0.1 mM or more and 50.0 mM or less. 16 . The production method according to claim 1 , wherein the coating liquid contains a calcium ion at a concentration of 0.1 mM or more and 20.0 mM or less. 17 . The production method according to claim 1 , wherein the coating liquid contains a calcium ion at a concentration of 0.2 mM or more and 10.0 mM or less.
Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin · CPC title
Insulins · CPC title
Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells · CPC title
obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide) · CPC title
Processes · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.